The multidisciplinary Milstein Program in Technology & Humanity will bring prominent thinkers to campus this spring for thought-provoking public events and workshops.
An experimental contraceptive drug candidate developed by Weill Cornell Medicine investigators temporarily stops sperm in their tracks and prevents pregnancies in preclinical models.
Cornell data scientists are developing models and mathematical techniques to address the world’s most vexing problems, from public health crises to climate change.
Cornell President Martha E. Pollack confirmed on March 20 that two members of the Ithaca campus community have tested positive for the COVID-19 coronavirus.
Following Gov. Cuomo’s new coronavirus restrictions on schools, businesses and religious gatherings, Orthodox Jewish leaders have voiced criticism that they are being singled out for the new surge of COVID-19 cases. Jonathan Boyarin, professor of modern Jewish studies and an expert on Jewish experience and culture, is available for interviews.
A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, according to a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Leroy Creasy ’60, M.S. ’61, whose research on the health benefits of grapes and red wine has spurred decades of public interest and scientific inquiry, died June 15 in Aurora, New York.
The President’s Visioning Committee on Cornell in New York City is holding an open forum and discussion Tuesday, March 27, from 4:30 to 5:30 p.m. in G10 Biotech.
K-12 schools across the country are closing or moving to online education to help control the spread of the coronavirus. Jamila Michener, assistant professor of government says during times of public health crisis the consequences of inequalities surface and it’s going to be a huge challenge to support K-12 students facing school closures at home and also in their communities.
